Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency Ablation of Pulmonary Tumors Response Evaluation: a Prospective, Intention-to-Treat, Multicenter Clinical Trial

NCT00690703 is registered in ClinicalTrials.gov with Angiodynamics, Inc. as lead sponsor.

NCT NCT00690703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00690703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency Ablation of Pulmonary Tumors Response Evaluation: a Prospective, Intention-to-Treat, Multicenter Clinical Trial
Lead sponsor
Angiodynamics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2001
Completion date
December 31, 2007
Enrollment
106 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer, pulmonary metastases